Elevation Oncology, Inc.
Biotechnology company · Boston, Massachusetts, United States
Elevation Oncology, Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $65 million sold in a notice filed in 2020.
Elevation Oncology at a glance
What does Elevation Oncology do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $65 million sold (2020).
Frequently asked questions about Elevation Oncology
Where is Elevation Oncology headquartered?
Elevation Oncology, Inc. is headquartered in Boston, Massachusetts, United States.
What does Elevation Oncology do?
Elevation Oncology, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
When was Elevation Oncology founded?
The earliest incorporation on record for Elevation Oncology, Inc. is in 2019, according to public company registers.
Similar companies
- Syntis Bio, Inc.Boston, Massachusetts, United States
- Strand Therapeutics Inc.Boston, Massachusetts, United States
- Pear Therapeutics, Inc.Boston, Massachusetts, United States
- Aura Biosciences, Inc.Boston, Massachusetts, United States
- Holobiome, Inc.Boston, Massachusetts, United States
- Leuko Labs, Inc.Boston, Massachusetts, United States
- Compass Therapeutics, Inc.Boston, Massachusetts, United States
- Odyssey Therapeutics, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences